Velcade Shows Edge In Phase III Multiple Myeloma Trial; Fails In Colorectal
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
Millennium plans to submit its Phase III Velcade (bortezomib) confirmatory trial in multiple myeloma in the second half of 2004.